Transcripts Viridian Therapeutics, Inc.

Equities

VRDN

US92790C1045

Market Closed - Nasdaq Other stock markets 01:30:00 10/05/2024 am IST			5-day change	1st Jan Change
13.91 ^USD	-6.64%		-4.60%	-36.13%

09/05	Oppenheimer Adjusts Viridian Therapeutics Price Target to $31 From $36, Maintains Outperform Rating	MT
09/05	B. Riley Downgrades Viridian Therapeutics to Neutral From Buy	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Viridian Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024	08/05
Transcript : Viridian Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 07:30 AM	11/01
Transcript : Viridian Therapeutics, Inc. - Special Call	18/12
Transcript : Viridian Therapeutics, Inc. - Special Call	11/23/11
Transcript : Viridian Therapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023	10/23/10
Transcript : Viridian Therapeutics, Inc., Q4 2022 Earnings Call, Mar 08, 2023	08/23/08
Transcript : Viridian Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 02:15 PM	10/23/10
Transcript : Viridian Therapeutics, Inc., Q3 2022 Earnings Call, Nov 14, 2022	14/22/14
Transcript : Viridian Therapeutics, Inc., Q2 2022 Earnings Call, Aug 15, 2022	15/22/15
Transcript : Viridian Therapeutics, Inc., Q1 2022 Earnings Call, May 12, 2022	13/22/13
Transcript : Viridian Therapeutics, Inc., Q4 2021 Earnings Call, Mar 10, 2022	11/22/11
Transcript : Viridian Therapeutics, Inc. - Shareholder/Analyst Call	03/21/03
Transcript : Viridian Therapeutics, Inc., Q4 2020 Earnings Call, Mar 25, 2021	26/21/26
Transcript : Viridian Therapeutics, Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-03-2021 11:40 AM	03/21/03
Transcript : Miragen Therapeutics, Inc. - Shareholder/Analyst Call	31/20/31
Transcript : Miragen Therapeutics, Inc., Viridian Therapeutics, Inc. - M&A Call	28/20/28
Transcript : Miragen Therapeutics, Q2 2020 Earnings Call, Aug 05, 2020	06/20/06
Transcript : Miragen Therapeutics - Special Call	23/20/23
Transcript : Miragen Therapeutics, Inc. - Shareholder/Analyst Call	21/20/21
Transcript : Miragen Therapeutics, Q1 2020 Earnings Call, May 07, 2020	08/20/08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Viridian Therapeutics, Inc.

Equities

VRDN

US92790C1045

Transcripts

Filters